How to Buy Myriad Genetics Stock
Myriad Genetics Inc
Myriad Genetics, Inc. , a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally.
Myriad Genetics stock last closed at $23.75, up 2.9% from the previous day, and has decreased 6.24% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.09 percentage points. Myriad Genetics stock is currently +70.62% from its 52-week low of $13.92, and -15.72% from its 52-week high of $28.18.
At the moment, there are 81.22M shares of MYGN outstanding. The market value of MYGN is $1.93B. In the past 24 hours, 562,040 MYGN shares were traded.
How to Buy Myriad Genetics Stock
Not sure how to invest in Myriad Genetics stock? Here's how.
- Choose where to buy Myriad Genetics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you determine where to buy Myriad Genetics stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Pick your method of payment and add your information.
- Evaluate Myriad Genetics stock: The Myriad Genetics ticker symbol is MYGN. Is Myriad Genetics stock a good investment? Should you buy shares of MYGN? How do MYGN's underlying business fundamentals look? Do top analysts think Myriad Genetics is a good buy? Why has MYGN's stock price moved recently? (Hint: Our stock research website can help you evaluate if MYGN is a good stock to buy).
- Place your MYGN trade: Decide if you will purchase MYGN shares at the current market price or use a limit order to purchase MYGN shares at a given price.
- Keep an eye on your MYGN investment: Create a watchlist to monitor your new investment in Myriad Genetics stock.
Step 1: Choose where to buy Myriad Genetics stock
You need an online brokerage account in order to access the NASDAQ market and buy MYGN shares.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in MYGN today.
How to Set Up a New Investment Account on eToro
- Click here to get started.
- Enter your personal details to start a new trading account.
- Send your info by hitting the "Create Account" button.
Step 3: Put funds into your investment account
Now that you have opened your account on a good online stock trading app, you need to deposit funds:
Watch this video walkthrough to see the process of transferring money into your new brokerage account.
Step 4: Evaluate Myriad Genetics stock
Once you have figured out the best place to buy Myriad Genetics stock, it's absolutely critical to research their stock prior to investing, so you actually wrap your head around the risk and opportunity.
Myriad Genetics Metrics
Myriad Genetics Fundamentals
WallStreetZen was created to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on MYGN's stock page.
How is MYGN stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge MYGN's true value.
Using relative valuations ratios:
- MYGN could be undervalued based on its P/B ratio of 2.18x, relative to Diagnostics & Research industry P/B ratio of 4.13x
You can access additional valuation analysis on MYGN's stock here.
MYGN Financial Health Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the MYGN balance sheet.
- MYGN has $114.90M in cash and short term investments. This is enough to cover its annual cash burn of $151.60M.
- There are more short-term assets than short-term liabilities on the MYGN balance sheet.
- MYGN has a low debt to equity ratio of 0.35.
Failed Financial Due Diligence Checks:
- MYGN has cash burn of 151600000. It does not have sufficient cash and short-term investments to cover this.
- Total MYGN debt is higher than 5 years ago, relative to shareholder equity.
- MYGN profit margin has gone down from -3.9% to -16.5% in the past year.
Do analysts think it's a good time to buy Myriad Genetics stock
Out of 3 Equities analysts who give forecasts on MYGN, the consensus analyst rating on Myriad Genetics is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent MYGN Analyst Forecasts
Mason Carrico, a bottom 6% analyst from Stephens & Co. maintains MYGN with a hold rating and raises their MYGN price target from $17.00 to $24.00, on Mar 6, 2023.
Andrew Cooper, a bottom 2% analyst from Raymond James maintains MYGN with a buy rating and raises their MYGN price target from $25.00 to $27.00, on Mar 3, 2023.
Puneet Souda, a bottom 2% analyst from SVB Leerink maintains MYGN with a hold rating and lowers their MYGN price target from $27.00 to $25.00, on Nov 2, 2022.
An analyst from Goldman Sachs maintains MYGN with a strong sell rating and lowers their MYGN price target from $26.00 to $23.00, on Apr 19, 2022.
You can dive deeper into what analysts are forecasting on the Myriad Genetics stock forecast page.
Metrics for Advanced MYGN Traders
Is MYGN Growing Revenue?
Last year, MYGN revenue was $678.40M. During the past 5 year, MYGN's revenue has gone up by -1.22% per year. This was slower than the Diagnostics & Research industry average of 16.31%.
Dig into MYGN's earnings and revenue performance here.
Are MYGN insiders buying or selling the stock?
Over the last year, executives and large shareholders at MYGN have sold more shares than they have bought.
Nicole Lambert, Chief Operating Officer of MYGN, was the latest MYGN insider to sell. They sold $299,817.34 worth of MYGN stock on Mar 2, 2023.
Learn more about who owns MYGN stock here.
Does MYGN stock generate passive income?
No, Myriad Genetics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your MYGN trade
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Click the Open button and your broker will place your order.
If you want more help investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your MYGN investment
Now that you own some shares in MYGN, you'll want to stay up-to-date on your new investment.
Make a watchlist to monitor your MYGN stock.
MYGN Feed
How to Buy Stock in Myriad Genetics
To summarize, here are the 6 steps you need to take to buy Myriad Genetics stock right now:
- Choose where to buy Myriad Genetics stock
- Open a brokerage account
- Put funds into your investment account
- Evaluate Myriad Genetics stock
- Place your MYGN trade
- Keep an eye on your MYGN investment
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Myriad Genetics, add MYGN to your watchlist by clicking the button below.
More Content You Might Enjoy
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.